160 related articles for article (PubMed ID: 7022095)
1. [Flufenazine decanoate in the ambulatory treatment of schizophrenic patients].
Populin M; De Vanna M; Poldrugo F
Minerva Psichiatr; 1981; 22(2):85-92. PubMed ID: 7022095
[No Abstract] [Full Text] [Related]
2. Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
Gaby N; Lefkowitz D; Israel JR
N C Med J; 1982 Sep; 43(9):641-4. PubMed ID: 6958987
[No Abstract] [Full Text] [Related]
3. The use of fluphenazine decanoate (Modecate)depot therapy in outpatient schizophrenics-a retrospective study.
Tan CT; Ong TC; Chee KT
Singapore Med J; 1981 Aug; 22(4):214-8. PubMed ID: 7323829
[No Abstract] [Full Text] [Related]
4. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
Polácek J
Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
[No Abstract] [Full Text] [Related]
5. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
Leong OK; Wong KE; Tay WK; Gill RC
Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796
[TBL] [Abstract][Full Text] [Related]
6. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
8. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
Zhang YF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
[No Abstract] [Full Text] [Related]
9. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
Ngui PW
Seishin Shinkeigaku Zasshi; 1983; 85(9):635-9. PubMed ID: 6676769
[No Abstract] [Full Text] [Related]
10. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
Jayaram G; Coyle J; Tune L
J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342
[TBL] [Abstract][Full Text] [Related]
11. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
Odejide OA; Aderounmu AF
J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
[TBL] [Abstract][Full Text] [Related]
12. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
[TBL] [Abstract][Full Text] [Related]
13. [Clinical observations of treatment with Lyorodin-depot (Jenapharm)].
Pirozynski T; Chiriţă V; Cosmovici N; Offenberg C; Chiriac ME; Marinescu V; Cojocaru M; Berlescu M; Mungiu A
Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):501-9. PubMed ID: 2700035
[TBL] [Abstract][Full Text] [Related]
14. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
MacCrimmon DJ; Saxena B; Foley P; Grof P
Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the therapeutic effectiveness of mirenil prolongatum and moditen depot in the treatment of schizophrenia].
Afeltowicz Z; Sep-Kowalikowa B; Zgirski L
Psychiatr Pol; 1976; 10(5):479-85. PubMed ID: 981421
[No Abstract] [Full Text] [Related]
16. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
Kong DS; Yeo SH
Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
[No Abstract] [Full Text] [Related]
17. Clinical experience with fluphenazine decanoate in the treatment of patients with long-standing chronic schizophrenia.
Christodoulidis H; Frangos H
Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):193-8. PubMed ID: 809234
[No Abstract] [Full Text] [Related]
18. [Prolonged treatment of schizophrenic psychoses with depot-fluphenazine ("lyogen decanoate")].
Bohacek N; Mihovilović M
Neuropsihijatrija; 1968; 16(3):69-73. PubMed ID: 5195835
[No Abstract] [Full Text] [Related]
19. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
Smulevich AB; Minsker EI; Mazaeva NA; Volkova RP; Lukanina SK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):912-20. PubMed ID: 5050051
[No Abstract] [Full Text] [Related]
20. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
[No Abstract] [Full Text] [Related]
[Next] [New Search]
